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Abstract
Background: Gastrointestinal stromal tumors are the most common mesenchymal neoplasms affecting the
gastrointestinal tract. The stomach is the most common location to be affected, and the rectum one of the rarest,
but the whole gastrointestinal tract remains susceptible. Gastrointestinal stromal tumors account for only 0.1% of
rectal tumors. Currently, endoscopic ultrasound plays an essential role in the diagnostic process of gastrointestinal
stromal tumors, especially when the affected sites have a worse outcome and higher morbidity rates.
Case presentation: We describe the case of a 68-year-old white Japanese man with a history of long-term mild rectal
pain and tenesmus. A digital rectal examination revealed a right palpable solid mass ranging from 3 to 7 cm from his
anal verge. A colonoscopy was performed and showed a 5 cm elevated lesion covered by normal mucosa, located 4 cm
above the pectineal line. Endoscopic ultrasound confirmed the diagnosis of a homogeneous hypoechoic mass with areas
of necrosis as a rectal subepithelial lesion originating at the fourth layer (muscularis propria). He then underwent
endoscopic ultrasound-guided fine needle aspiration of the lesion, followed by cytological and immunohistochemistry
evaluation. The evaluation showed spindle and epithelioid cells of variable sizes, in fascicles separated by stroma, which
reacted firmly and consistently to CD117/c-kit and CD34, and negative to desmin and S-100 protein. There was weak
staining for nuclear Ki-67 in the tumor cells. A diagnosis of rectal gastrointestinal stromal tumor was confirmed. After a
multidisciplinary meeting, an abdominoperineal resection of his rectum was performed. The pathology of the specimen
confirmed the diagnosis of rectal gastrointestinal stromal tumor. He is now asymptomatic after 3 months’ follow-up and is
on adjuvant therapy with a tyrosine-kinase inhibitor.
Conclusions: Gastrointestinal stromal tumors are rare tumors, and among the variety of primary location sites, the rectum
is one of the rarest. The localization of this type of tumor has worse outcomes and higher morbidity rates. We report this
rare case to emphasize the need for precise diagnosis and the important role of endoscopic ultrasound-guided fine
needle aspiration in such situations.
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Background
Gastrointestinal stromal tumors (GISTs) are the most com-
mon mesenchymal neoplasm affecting the gastrointestinal
tract [1]. Along with other mesenchymal malignancies,
such as leiomyomas, leiomyosarcomas, schwannomas, and
lipomas, they present as subepithelial tumors (SETs). For
this reason, endoscopic evaluation with standard biopsy
does not obtain sufficient tissue for a definitive diagnosis, as
it provides only mucosal tissue sampling [2, 3]. Histological
diagnosis is essential because treatment and prognosis vary
widely among the pathologies mentioned above.
Endoscopic ultrasound (EUS) is an important diagnostic
tool for managing GISTs and other SETs. This method
provides echographic features that suggest a precise diag-
nosis, as well as features that may be associated with
malignancy [4, 5]. Furthermore, an EUS-guided biopsy is
the preferred technique for tissue acquisition of SETs and
for definitive morphological diagnosis [6].
This case report illustrates an interesting clinical
scenario of a GIST which has been identified in an
unusual location, in which EUS plays a key role in
diagnosis.
Case presentation
This is the case of a 68-year-old white Japanese man
with a history of long-term mild rectal pain and tenes-
mus for the last year, denying lower gastrointestinal
bleeding and weight loss. Hypertension is his only
comorbidity; it is treated with losartan 50 mg adminis-
tered orally daily. His father died of acute myocardial
infarction and his mother died of metastatic gastric
cancer. He denied alcohol abuse and any drug addiction
including tobacco. Concerning his history of surgery, he
had an uncomplicated laparoscopic cholecystectomy due
to gallstones 10 years ago. At the first medical consult-
ation, he presented awake and alert, appeared healthy,
and looked his stated age. His vital signs were within
normal limits, with a blood pressure of 130×70 mmHg
and a heart rate of 80 beats per minute (bpm) assessed
by radial pulse palpation. A head and neck examination
were also normal. An examination of his lungs revealed
normal resonant percussion and auscultation was clear.
Heart auscultation showed S1 heard best at apex with
normal intensity and S2 heard best at base, normal split-
ting, without any extra sounds. Observation of his abdo-
men evinced four small laparoscopic scars and
auscultation found slightly hyperactive bowel sounds.
Abdominal palpation found neither tenderness nor
masses. Regarding proctologic examination, an inspection
of his anus found no lesion. A digital rectal examination
revealed normal anal sphincter tone but showed a right
palpable solid mass ranging from 3 to 7 cm from his anal
verge. There was no blood on stool and his bulbocaverno-
sus reflex was preserved.
The investigation proceeded with a colonoscopy that
showed a 5 cm elevated lesion covered by normal
mucosa, located 4 cm above the pectineal line. Comple-
mentary pelvic magnetic resonance imaging revealed a
well-defined round tumor arising from his distal rectum
associated with mild colon distension (Figs. 1 and 2).
There were no signs of prostatic or bladder invasion. His
urine analysis was within normal limits.
An EUS was then performed and confirmed the diagnosis
of a homogeneous hypoechoic mass with areas of necrosis
as a rectal subepithelial lesion originating at the fourth layer
(muscularis propria; Fig. 3). EUS-guided fine needle aspir-
ation (FNA) of the lesion was performed (Fig. 4), followed
by cytological and immunohistochemistry evaluation,
Fig. 1 Axial T1-weighted magnetic resonance image shows a well-defined round mass, with low signal intensity on T1-weighted image and on
T2-weighted image, arising from the distal rectum
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Fig. 2 Sagittal T2-weighted magnetic resonance image shows hyperintense areas of the distal rectum mass, showing no invasion to bladder or prostate
Fig. 3 Endoscopic ultrasound showing a homogeneous hypoechoic mass with areas of necrosis as a rectal subepithelial lesion originating at the
fourth layer (muscularis propria)
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showing spindle and epithelioid cells of variable sizes, in
fascicles separated by stroma. The cell borders were well
defined, and their nucleus varied from oval to spindle-
shaped with smooth membranes. The chromatin was
coarsely granular and their cytoplasm was scant. The cell
block preparation was extremely helpful in this case,
particularly for immunostains, which confirmed the diagno-
sis of rectal GIST. The cells reacted strongly and consist-
ently to CD117/c-kit and CD34, and negative for desmin
and S-100 protein. There was weak staining for nuclear
Ki-67 in tumor cells (Fig. 5). After a multidisciplinary meet-
ing, an abdominoperineal resection of his rectum was
decided. He underwent surgery; pathology of the specimen
confirmed the diagnosis of rectal GIST. He is now asymp-
tomatic after 3 months’ follow-up and is on adjuvant
therapy with tyrosine-kinase inhibitor determined by our
local Oncology group.
Discussion
GISTs are mesenchymal tumors that display differenti-
ation toward the lineage of interstitial cells of Cajal [7]
and typically express CD117/c-kit. Recent studies
showed that these cells play a fundamental role in
gastrointestinal motility because they conduct inputs
from enteric motor neurons, generating intrinsic elec-
trical rhythmicity in phasic smooth muscles [8]. On
histological examination, the cells of Cajal are at the
fourth layer (muscularis propria) [8, 9]. For that reason,
GISTs present as SETs.
A definitive diagnosis of a GIST tumor depends on the
association of histological and immunohistochemical find-
ings. On histological examination, there are three types of
GIST: spindle cell type (70%), epithelioid (25%), and mixed
subtype (5%) [10]. The most sensitive and specific immuno-
histochemistry marker is CD117/c-kit while other standard
markers are platelet-derived growth factor receptor-alpha
(PDGFR-α) and CD34 [7]. Nonetheless, recent studies
showed that a new marker, Discovered On GIST-1 (DOG-1),
plays a significant role in diagnostic yield of GIST tumors,
especially when CD117 expression has not been demon-
strated. Therefore, DOG1 has recently been recom-
mended to be part of the routine diagnostic panel [11].
GISTs are equally distributed between genders, with a
mean age of presentation of 60 to 65-years old (ranging
from 10 to 100 years) [12]. Although GISTs are a rare type
of cancer, they are the most common sarcoma of the
gastrointestinal tract [1] with an estimated incidence of 1/
100,000 per year [13]. Treatment is responsible for an
enormous financial impact; the estimated cost per month
per patient is approximately US$4000 for non-recurrent
cases and more than US$8000 for recurrent cases [14].
Approximately 80% of patients are symptomatic, des-
pite the non-specificity of symptoms (mild abdominal
pain, gastrointestinal bleeding, and fatigue due to iron
deficiency anemia). The most common primary affected
site is the stomach while esophagus, colon, and rectum
are the rarest [12]. GISTs account for only 0.1% of cases
of rectal tumors [15].
Fig. 4 Endoscopic ultrasound-guided fine needle aspiration of the subepithelial lesion originating at the fourth layer (muscularis propria)
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Characteristics identified clinically and on esophago-
gastroduodenoscopy (EGD) are well known to help
differentiate between GISTs and non-GIST SETs. Patients
of an older age, tumor site location outside the gastric
cardia, large tumor size, exophytic growth pattern, and
ulceration or dimpling are independent preoperative pre-
dictive factors for GISTs versus non-GISTs [16].
Metastatic progression of GISTs it is not uncommon.
It is expected that almost 30% of all completely resected
GISTs will recur within 2 years [17]. Most of the recur-
rences are disseminated, especially involving the liver
and peritoneum [18]. Patients presenting a metastatic
GIST are treated mainly with imatinib (tyrosine-kinase
inhibitor) therapy and the median overall survival rate is
5 years [19]. In this context, positron emission tomog-
raphy (PET) with 18F-fluorodeoxyglucose (18F-FDG)
tracer may provide valuable information. A recent sys-
tematic review showed that 18F-FDG PET was a strong
predictor of clinical outcome and in assessing treatment
response [20]. Other studies found that it provides a
timelier and more accurate response assessment com-
pared to a computed tomography (CT) scan and mag-
netic resonance imaging (MRI) [21]. Moreover, 18F-FDG
PET may provide information about the malignancy: a
tumor presenting maximum standardized uptake value
(SUV) greater than 3.0 has a high malignant potential
even in small tumors (<2 cm) [22]. Therefore, this im-
aging modality should be considered in all cases of
GISTs, especially in metastatic disease, and while moni-
toring treatment response.
Regarding EUS evaluation, GISTs are seen as fourth layer
tumors. The main differential diagnoses are leiomyoma,
leiomyosarcoma, and schwannoma [23]. Precise diagnosis
is essential because each of the pathologies mentioned
above has a different treatment, follow-up, and prognosis.
For small leiomyomas (<2 cm), surveillance annually with
Fig. 5 Rectal stromal tumor, immunohistochemistry immunostains. a Cell block showing syncytial tissue fragment with mixed spindle and
epithelioid cells. Hematoxylin and eosin. b A strong positive staining with CD117/c-kit. c Strong positive reaction with CD34. d Negative reaction
with desmin. e Negative reaction with S-100 protein. f Weak nuclear staining for Ki-67 in tumor cells
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EGD may be performed [24, 25]. If the lesion is larger,
symptomatic, or growing, then surgical resection is advised.
Small leiomyomas (<2 cm) may be treated with endoscopic
resection instead of surgical resection. The endoscopic
resection of leiomyomas has lesser perforation rates than
GISTs resection [26]. Leiomyosarcomas have a worse prog-
nosis compared to GISTs, as their recurrence rate and
subsequent metastasis rate may reach 70% and 80%
respectively [27]. Schwannomas are benign tumors that
tend to recur locally and to become malignant. Their
response to chemotherapy and radiotherapy remains uncer-
tain [28]; consequently, the treatment of choice for schwan-
nomas is surgical resection with free margin. If they are
uniformly benign, the long-term outcome is excellent [29].
Furthermore, the standard treatment for GISTs is open or
laparoscopic surgical resection with free margins [30],
although recent studies demonstrated the feasibility and
safety of endoscopic resection through an endoscopic sub-
mucosal dissection (ESD) technique for small tumors.
GISTs have been associated with a relatively low recurrence
rate during long-term follow-up despite little R0 resection
rate [31]. Other prospective multicenter studies are needed
to assess the real role of endoscopy in the treatment of
GISTs, but initial data are encouraging. Such differences
among SETs enhance the need of a precise histological
diagnosis. GISTs in a rectal location are related to worse
outcomes compared to other sites [13]; this adds emphasis
to the importance of precise and early diagnosis as in our
reported case.
In this context, EUS is an important method that pre-
sents excellent diagnostic rates and may provide material
for cytological and histological evaluation [4]. As previ-
ously described, GISTs are fourth layer tumors, which
are hypoechoic and homogeneous. Differential diagnoses
are leiomyoma and schwannoma [23]. Some echographic
characteristics to differentiate GISTs from other fourth
layer tumors have already been described in the litera-
ture. GISTs and schwannomas usually exhibit a
complete or incomplete marginal hypoechoic halo, while
leiomyomas do not show any clear marginal halo. Also,
GIST echogenicities, in general, are low but slightly
higher than that of the normal surrounding fourth
muscle layer (muscularis propria), whereas the level of
echogenicity in leiomyomas was nearly equal to that of
the surrounding typical muscularis propria layer, and the
echogenicity in schwannomas was extremely low. The
difference in echogenicities among the fourth layer
tumors (mesenchymal) might reflect the structural com-
ponents and pathological differences of cellularity of
these tumors [5].
Despite these characteristics, diagnostic accuracy for
third and fourth layer tumors by EUS alone is around 50%
[32]. A recent study proposed a scoring system for diagno-
sis of GISTs and other SETs based on EUS characteristics
and found sensitivity and specificity to be 75% and 85%,
respectively, for GISTs. However, this study only enrolled
gastric SETs and had not been validated yet [33]. There-
fore, a complementary biopsy is mandatory. Despite its
high rates of inadequate material acquisition [6], FNA
biopsy is still currently considered the procedure of choice
for preoperative diagnosis of GISTs. The average diagnos-
tic accuracy rate of EUS-guided FNA ranges from 60 to
80% in SETs [34]. Recent studies showed that Trucut
biopsy is related to greater accuracy rates, and that should
be preferred over FNA [35, 36]. Others studies propose
dual biopsy (FNA and Trucut) to increase diagnostic yield
[37]. However, there is no consensus yet, and hence FNA
remains as the most performed procedure. To the best of
our knowledge, no study assessed the sensitivity and
specificity of the association of EUS features and Trucut
or EUS-guided FNA.
Besides diagnostic yield, EUS also provides prognostic
information: specific ultrasonography characteristics
related to malignancy in GIST. Size larger than 20 mm,
presence of cystic spaces, surface ulceration, irregular
borders, and echogenic foci are unique features predict-
ive of the malignant potential of GISTs and, therefore,
worse outcomes [6, 38]. Among them, tumor size is the
most important factor.
Other imaging methods may be useful for identifica-
tion and to make the correct diagnosis of rectal GISTs.
Because the rectum is an unusual location for a GIST,
few studies assessed the role of MRI and a CT scan, but
features such as large well-circumscribed masses and
exophytic masses with moderate and heterogeneous en-
hancement on CT and MRI are associated with rectal
GISTs. Furthermore, invasion of adjacent organs is
uncommon, as well as regional lymph node enlargement,
and small bowel obstruction [39]. If present, however,
these must be identified and treated accordingly.
Finally, a combination of clinical, radiological, endo-
scopic, ultrasonographic, and cytological characteristics
could eventually compose a scoring system, which would
objectively enhance the preoperative diagnostic rates of
GISTs and other SETs. Which would, therefore, help
physicians to decide more accurately whether to, how to,
and when to treat their patients.
Conclusions
GISTs are rare tumors, and among their variety of primary
locations the rectum is one of the rarest. This tumor loca-
tion site has worse outcomes and higher morbidity rates.
We report this rare case to emphasize the need for precise
diagnosis and the important role of EUS-guided FNA in
such situations. More studies and new technology are re-
quired to assess which is the best diagnostic approach for
SETs and GISTs. For now, EUS-guided FNA is essential.
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